Introduction
During the asymptomatic phase of human immunodeficiency virus type 1 (HIV-1) infection, the amount of HIV-1 in vivo remains at a low level, but it increases at a later stage (Ho et al., 1989 ; Simmonds et al., 1990 ; Piatak et al., 1993) . Clinical studies of virus dynamics following anti-HIV chemotherapy have demonstrated continuous virus production in vivo, even at the asymptomatic stage (Pantaleo et al., 1993 ; Embretson et al., 1993 ; Ho et al., 1995 ; Wei et al., 1995) .
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Fax j81 3 5803 0235. e-mail kann.impt!med.tmd.ac.jp Nevertheless, the amount of HIV-1 at this stage is usually low. This is presumed to reflect a balance between virus replication and anti-viral host defence mechanisms.
Cultured peripheral blood mononuclear cells (PBMC) of asymptomatic HIV-1 carriers (ACs) do not show induction of replication of endogenous HIV-1 and they do not support the production of exogenously inoculated HIV-1 in the presence of CD8 + T lymphocytes (Walker et al., 1986) . Such CD8 + cellmediated suppression may play an important role in the persistence of the asymptomatic stage, as observed in ACs but not in uninfected individuals or AIDS patients (Kannagi et al., 1990 ; Landay et al., 1993) . Similar CD8 + cell-mediated suppression of virus replication is observed in simian immuno-T. Ohashi and others T. Ohashi and others deficiency virus-infected macaques and HIV-1-infected chimpanzees (Kannagi et al., 1988 ; Castro et al., 1991) .
It is well known that HIV-1-specific CD8 + cytotoxic T lymphocytes (CTL) exist in fresh clinical material from HIV-1-infected individuals. CTL activity against target cells expressing HIV-1 antigens can be detected following cell lysis (Walker et al., 1987 (Walker et al., , 1988 Plata et al., 1987 ; Koenig et al., 1990) . Elimination of HIV-infected cells by CTL would limit HIV-1 production. These observations are in agreement with the clinical importance of CTL in the acute phase of HIV-1 infection (Koup et al., 1994) . However, cell killing may not be the only mechanism of CD8 + T cell-mediated suppression. Absence of massive cell killing in suppressed cultures and the suppressive potential of supernatants of CD8 + cells suggest that non-cytotoxic CD8 + T-cell factors could also be involved in suppression (Walker & Levy, 1989 ; Brinchmann et al., 1990) .
Several chemokines, including MIP-1α, MIP-1β, RANTES, SDF-1 and MDC, suppress HIV-1 replication (Cocchi et al., 1995 ; Bleul et al., 1996 ; Oberlin et al., 1996 ; Pal et al., 1997) . However, CD8 + cell-mediated suppression is not neutralized by antibodies to CC chemokines Mackewicz et al., 1996) and there is poor clinical and experimental correlation between these chemokines and CD8 + cell-mediated suppression (McKenzie et al., 1996 ; Lacey et al., 1997) . Moreover, the natural major producers of chemokines are not CD8 + cells. IL-16 produced by CD8 + cells limits virus transcription (Baier et al., 1995) but correlates poorly with CD8 + cell-mediated suppression (Mackewicz et al., 1996) . Therefore, while these factors certainly suppress HIV-1 replication, they do not seem to be the major components of CD8 + cell-mediated suppression.
CD8 + cell-mediated suppression of HIV-1 replication has been demonstrated by several investigators (Walker et al., 1986 ; Kannagi et al., 1990 ; Brinchmann et al., 1990 ; . Although the involvement of soluble factors has been suggested, the precise mechanism(s) of CD8 + cellmediated suppression remains to be defined. Variability of experimental systems is one of the reasons for the difficulty in understanding this phenomenon. Another reason for the difficulty is the erratic detection of suppressive activity in supernatants of AC CD8 + cells. The frequency of detection and the magnitude of suppression by supernatants vary widely among ACs. In contrast, a direct mixture of AC CD8 + cells and infected CD4 + cells reliably elicits significant suppression. It is not known whether the cell-free and cell-cell suppression activities result from quantitative variation of one phenomenon or totally different ones or whether cell contact-dependent suppression is distinguishable from CTL effects.
In the present study, we have divided the cell contactdependent CD8 + T lymphocyte-mediated suppression of HIV-1 replication into MHC I-restricted and -unrestricted suppression. We report that MHC I-unrestricted, CD8 + cellmediated HIV-1 suppression was detected against CD4 + PBMC but not against an established cell line, ILT-KK, while ILT-KK cells were susceptible to MHC I-restricted suppression. We discuss the role of these mechanisms in HIV-1 carriers at various stages of infection.
Methods
In vitro HIV-1 infection of PBMC. Asymptomatic HIV-1 carriers, randomly selected from the Outpatient Department, with a peripheral CD4 + T lymphocyte count of 200\µl, and uninfected healthy laboratory workers served as blood donors in most experiments. Blood samples were also obtained from HIV-1-infected individuals with peripheral CD4 + T lymphocyte counts of 50-200\µl and 50\µl, defined as late and advanced stages, respectively. PBMC were isolated on a Ficoll-Paque (Pharmacia Biotech) gradient and stimulated with 1 % phytohaemagglutinin (PHA) (Difco) for 3 days. Cells were washed and cultured in RPMI 1640 medium (Gibco) containing 2 ng\ml recombinant IL-2 (Shionogi) and 10 % FCS (Whittaker) and used for experiments within 1 week of PHA stimulation. For HIV-1 infection, CD4 + PBMC were separated as described below and incubated with culture supernatants containing HIV-1 (m.o.i. 0n1-0n01) at 37 mC for 1 h, extensively washed and then cultured in a medium containing IL-2 for indicated time intervals. HIV-1 utilized for in vitro infection was a filtered culture supernatant of MOLT-4\HIV-1 LAI C-3 cells (Harada et al., 1987) . For HIV-1 infection in some experiments, 10% mitomycin C (MMC)-treated (Sigma) CD4 + PBMC, infected with HIV-1 LAI or NFN-SX (O'Brien et al., 1990) for 18 h, were added to the well containing uninfected target cells.
Human T-lymphotropic virus type 1 (HTLV-I)-transformed T cell line. An IL-2-dependent, HTLV-I-transformed T cell line (ILT-KK) was established from PBMC of an AC by co-culturing with HTLV-Iinfected ILT-8M2 cells treated with MMC (Kannagi et al., 1991) . ILT-KK cells were maintained in RPMI 1640 medium supplemented with 10 % FCS and 2 ng\ml recombinant IL-2 and used as targets for HIV-1 infection.
Preparation of CD4 M or CD8 M T cell-depleted PBMC fractions and co-culture of both fractions. Depletion of CD4 + or CD8 + cells was achieved by using a magnetic particle concentrator following incubation of PBMC with Dynabeads M-450 (Dynal) coated with anti-CD4 or anti-CD8 antibody, respectively. In some experiments, a positively isolated CD8 + fraction from a magnetic cell sorter system (Miltenyi Biote) was also used. CD8 + cell-depleted fractions contained 9 % CD8 + cells, as confirmed by flow cytometric analysis. For direct mixed culture, 3i10% CD4 + cells and 10& CD8 + cells were placed in a well of a round-bottomed 96-well plate in a total of 200 µl medium. In some experiments, co-culture was performed on a larger scale by using wells of a 24-well plate. In this case, CD4 + and CD8 + cells were added at 3i10& and 10' per well, respectively, in 2 ml medium. For an indirect mixed culture, 3i10& CD4 + cells were placed in a culture insert with a porous membrane (0n4 µm pore size, Becton Dickinson) and cultured in a well of a 24-well plate containing 10' CD8 + cells.
Quantification of HIV-1 p24. In most experiments, the effect of CD8 + cells on HIV-1 production was evaluated by the relative amount of HIV-1 p24, which was calculated as the percent ratio of the value from a well containing HIV-1-infected CD4 + and CD8 + cells (prepared in a single well) to the mean value of duplicate wells with infected CD4 + cells alone. The mean deviations in the duplicates did not exceed 10n4 % of the mean. HIV-1 p24 antigen in culture supernatants was measured with an enzyme immunoassay system, EIA-II (Abbott Diagnostika).
Cytotoxicity assay. HIV-1-specific cytotoxicity was measured by &"Cr-release assay. Target ILT-KK cells expressing HIV-1 gp160 were prepared by incubation with recombinant vaccinia virus vSC25 et al., 1986 ; generously provided by B. Moss, National Institutes of Health, Bethesda, MD, USA) at an m.o.i. of 10 for 16 h. These cells were labelled with &"Cr for 1 h, washed and then incubated with CD4 + cell-depleted PBMC at various effector-to-target cell ratios for 6 h prior to measuring radioactivity in the supernatants. Specific cytotoxicity (%) was calculated as 100i(experimental release kspontaneous release)\(maximum releasekspontaneous release). Spontaneous release did not exceed 30 % of the maximum release.
Results

CD8 M T cells of ACs suppress HIV-1 replication in CD4 M PBMC even without matched MHC I
HIV-1 replication in activated CD4 + PBMC was suppressed by CD8 + T lymphocytes of ACs. In the first series of experiments, we examined the effectiveness of CD8 + T cellmediated suppression against autologous and allogeneic CD4 + PBMC. CD8 + cells from AC and seronegative (SN) donors were co-cultured with CD4 + PBMC exogenously infected with HIV-1 LAI. As shown in Fig. 1 (a) , CD8 + cells from all ACs caused a significant suppression of HIV-1 replication in CD4 + PBMC, even when the target cells did not share any human leukocyte antigen (HLA) with the effectors. The level of suppression by CD8 + cells was greatest when autologous CD4 + cells were used as the target. This inhibition was dependent on the number of CD8 + T cells, regardless of the share of MHC I (Fig. 1 b) . CD8 + cells from uninfected donors affected HIV-1 replication only marginally, irrespective of MHC I. CD8 + cell-mediated inhibition was still present after 7 CBB T. Ohashi and others T. Ohashi and others days of co-culture and was highly effective when HLA-A-or HLA-B-matched CD8 + cells were used (Fig. 1 c) . These results indicate that both MHC-unrestricted and -restricted suppression activities existed in CD8 + T cells from ACs and that a considerable part of the suppression was unrestricted with MHC I.
Requirement for cell contact for MHC I-unrestricted suppression of HIV-1 replication
To assess the possible involvement of soluble factors in CD8 + cell-mediated suppression of HIV-1, we compared HIV-1 production in co-cultures of directly mixed CD4 + and CD8 + cells with that in co-cultures of CD4 + and CD8 + cells separated by a semi-permeable membrane. Table 1 summarizes the results of several experiments performed on different occasions with different PBMC donors. In any combination tested, a directly mixed co-culture of infected CD4 + cells with AC CD8 + cells produced more efficient suppression of HIV-1 replication than in the semi-permeable membrane-separated co-cultures, irrespective of HIV-1 strain or MHC I matching. Although the separated co-cultures of CD4 + cells with AC CD8 + cells generally elicited moderate and variable effects on HIV-1 replication, more than 50 % suppression was observed in two of ten cases, suggesting the presence of a diffusible suppressive factor(s) in sporadic cases. Fig. 2 demonstrates the results of simultaneous experiments against T cell-tropic HIV-1 LAI and macrophage-tropic NFN-SX with an MHC Imismatched combination of CD4 + and AC CD8 + cells. Against HIV-1 LAI, direct co-culture resulted in a significant suppression of HIV-1 replication. The separated co-culture failed to suppress HIV-1 LAI production, even after an 18 h preincubation of both T cell populations before infection (Fig. 2 a, B-C). When HIV-1 NFN-SX was used as the virus source, however, CD8 + cells from the same donor showed low levels of transferable suppression, which became more effective after pre-incubation (Fig. 2 b, B-C) .
Thus, MHC I-unrestricted suppression of HIV-1 replication occurred mainly through cell-contact, although diffusible factors may also be involved, particularly against macrophagetropic HIV-1.
MHC I-restricted suppression of HIV-1 replication by CD8 M T lymphocytes of ACs in transformed T cells
Next, we examined whether CD8 + T cells of ACs could suppress HIV-1 replication in cells of an established cell line rather than PBMC (Fig. 3) . The cell line used as the target for HIV-1 infection was ILT-KK, an IL-2-dependent HTLV-Itransformed T cell line established from an HIV-1 carrier. This cell line did not carry endogenous HIV-1. ILT-KK cells were infected with HIV-1 LAI in vitro and co-cultured with CD8 + CBC HIV-1 suppression and MHC I restriction HIV-1 suppression and MHC I restriction transformed T cells as well as in PBMC but the suppression was restricted with MHC I.
HIV-1-specific CTL activity in MHC I-matched AC PBMC
We also tested the susceptibility of ILT-KK cells to the cytotoxic effects of CD8 + cells from MHC I-matched AC PBMC (Fig. 4) . ILT-KK cells infected with vSC25, a vaccinia virus-HIV-1 gp160 recombinant, were used as target cells. CD8 + PBMC from an AC, which shared HLA-A24 and -B52 CBD T. Ohashi and others T. Ohashi and others with the target, showed significant cytotoxicity, specifically against ILT-KK expressing HIV-1 antigen. MHC I-matched CD8 + PBMC from an uninfected donor showed little or no effect. Thus, ILT-KK cells became susceptible to MHC Imatched CD8 + PBMC of AC when expressing HIV-1 antigen, suggesting that the MHC I-restricted suppression of HIV-1 replication in this cell line is mediated by CTL.
MHC I-restricted and -unrestricted suppression of HIV-1 replication in HIV-1 carriers at various stages of infection
CD8 + T cells of ACs suppressed HIV-1 replication in both an MHC I-restricted and -unrestricted manner. Predominantly MHC I-restricted suppression was detected against MHC Imatched ILT-KK cells and MHC I-unrestricted suppression was detected against MHC I-mismatched PBMC. Suppression of replication in MHC I-matched PBMC is presumed to result from the complementary effects of both types of suppression. We next examined MHC I-restricted and -unrestricted CD8 + T cell-mediated suppression in HIV-1 carriers at various stages of infection.
As explained above, HIV-1-infected individuals were classified into three groups according to the number of peripheral CD4 + lymphocytes, i. 
Discussion
In the present study, we have demonstrated MHC Irestricted and -unrestricted suppression of HIV-1 replication by AC CD8 + cells. AC CD8 + cells possessed cell contactdependent, MHC I-unrestricted HIV-1 suppression activity and this activity was markedly reduced at late stages with CD4 + cell counts of 50-200\µl. In addition, a clear MHC Irestricted suppression by AC CD8 + cells was also demonstrated. This was presumably mediated by CTL and was conserved until the late stages. The presence of CTL activity at these stages has also been observed by others (Hoffenbach et al., 1989) . Our results suggest that the remaining CTL activity in the absence of MHC I-unrestricted suppression may lead to lysis of HIV-1-infected cells, resulting in a dramatic decline in CD4 + T cells in the advanced stage of the infection.
The mechanism of CD8 + cell-mediated HIV-1 suppression is one of the most important issues to be clarified. It probably consists of a complex of the multiple mechanisms that appear fragmentarily in a variety of previously reported experimental systems. Several investigators have suggested the presence of soluble suppressive factors that may be involved in mediating HIV-1 suppression. In the present study, we observed such activity sporadically in some but not all AC samples. In the present system, however, even when the focus was on MHC I-unrestricted suppression, the suppression of T cell-tropic virus was mediated mainly by cell-contact mechanisms. This indicates that the molecules responsible for this T-tropic virus CBE suppression may be membrane bound or hardly diffusible. As for the suppression of macrophage-tropic virus, our results showed the additional involvement of diffusible factors. These factors may include certain previously identified β-chemokines, such as MIP1-α, MIP1-β and RANTES (Cocchi et al., 1995) .
Suppression of HIV-1 replication by CTL in established cell lines has been well characterized (Yang et al., 1996) . HIV-1 suppression in ILT-KK is likely to be mediated by CD8 + cells, as MHC I restriction and antigen-specific cytotoxicity of the effector cells are consistent with the characteristics of CTL. In the present study, CTL seemed also to be effective against PBMC, since higher suppressive effects in PBMC were elicited by autologous or MHC I-matched CD8 + cells. However, even a totally mismatched MHC I combination of CD4 + and AC CD8 + cells sometimes showed comparable levels of suppression, suggesting that the MHC I-restricted mechanism may be complementary to the MHC I-unrestricted mechanism.
It is of note that MHC I-mismatched AC CD8 + cells suppressed HIV-1 replication in PBMC but not in ILT-KK cells. The reason for the resistance of ILT-KK cells to AC CD8 + cells is not clear. Since HTLV-I causes the enhanced expression of many cellular factors responsible for cell proliferation or virus replication, ILT-KK cells may modify the signalling pathways that are necessary for MHC I-independent suppression of HIV-I replication. This phenomenon remains to be clarified in future studies.
The magnitude of both MHC I-restricted and -unrestricted, CD8 + cell-mediated HIV-1 suppression was high in ACs but low in AIDS patients. This is in agreement with previous reports of the kinetics of CTL activity in HIV infection (Carmichael et al., 1993 ; Klein et al., 1995) . Such parallel behaviour over the course of the infection suggests perhaps that both types of suppression might be mediated by the same cell population. Recent reports, indicating that some HIV-1-specific CTL clones suppress HIV-1 replication in PBMC in an MHC I-unrestricted manner, support this possibility (Yang et al., 1997) . However, our present results indicate a discrepancy between the two types of suppression, observed in patients with CD4 + cell counts of 50-200\µl. This raises two possibilities : (i) the CD8 + cell populations mediating the two types of suppression may be different and destruction of the population that mediates MHC I-unrestricted suppression occurs or (ii) a single CD8 + cell population may mediate both types of suppression but MHC I-unrestricted suppression could be eliminated by other inflammatory factors (Kinter et al., 1996 ; Kubo et al., 1997) . Further studies are required to discriminate between these possibilities.
In conclusion, both MHC I-restricted and -unrestricted CD8 + cell-mediated mechanisms contribute to the suppression of HIV-1 replication in the asymptomatic stage. In the late stages of the infection, elimination of MHC I-unrestricted suppression occurred earlier than the restricted type, which may further influence the progression of the infection, allowing virus multiplication and cell destruction.
